News summaryThe Motley FoolOct 29, 2026, 07:38 PM
Merck (MRK) Q3 2026 Earnings Call Transcript
Merck reported third-quarter 2026 revenue of $18.1 billion, up 5% year over year. [[fact-7h28o1xt8]] Third-quarter earnings per share were $2.49, including a $0.12-per-share charge related to a license agreement. [[fact-8s5ozc6jm]] Sales of the KEYTRUDA family of products increased 6% to $8.6 billion. [[fact-osp00qw1p]] Gardasil sales were $2 billion, an increase of 14%. [[fact-2v3avdx2q]] The company expects 2026 revenue of $66.8 billion to $67.3 billion, representing growth of 3% to 4%. [[fact-zqfwzt7pi]]